Biomolecular Factors Represented by Bcl-2, p53, and Tumor-Infiltrating Lymphocytes Predict Response for Adjuvant Anthracycline Chemotherapy in Patients with Early Triple-Negative Breast Cancer

Bacinschi XE, Zgura A, Safta I, Anghel R

Cancer Management and Research 2020, 12:11965-11971

Published Date: 20 November 2020